CNI(CNI)
CNI
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $18.01B | $18.79B | $19.82B | $21.14B | $21.79B |
| Low | $17.79B | $18.28B | $19.36B | $20.65B | $21.29B |
| High | $18.60B | $19.76B | $20.60B | $21.98B | $22.65B |
| EBITDA Avg | $9.69B | $10.10B | $10.66B | $11.37B | $11.72B |
| Low | $9.57B | $9.83B | $10.41B | $11.10B | $11.45B |
| High | $10.00B | $10.63B | $11.08B | $11.82B | $12.18B |
| EBIT Avg | $7.73B | $8.07B | $8.51B | $9.07B | $9.35B |
| Low | $7.64B | $7.85B | $8.31B | $8.86B | $9.14B |
| High | $7.99B | $8.48B | $8.84B | $9.43B | $9.72B |
| Net Income Avg | $4.92B | $5.47B | $6.04B | $6.60B | $6.97B |
| Low | $4.80B | $5.25B | $5.86B | $6.40B | $6.76B |
| High | $5.04B | $5.81B | $6.35B | $6.94B | $7.33B |
| EPS Avg | $7.88 | $8.78 | $9.68 | $10.59 | $11.18 |
| Low | $7.69 | $8.42 | $9.39 | $10.27 | $10.84 |
| High | $8.08 | $9.31 | $10.18 | $11.13 | $11.75 |
| Analysts (Rev / EPS) | 16 / 18 | 16 / 18 | 14 / 9 | 15 / 10 | 15 / 8 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $4.43B | $4.68B | $4.61B | $4.73B | $4.63B | $4.92B | $4.93B | $5.15B |
| Low | $4.32B | $4.54B | $4.46B | $4.58B | $4.48B | $4.77B | $4.78B | $4.99B |
| High | $4.66B | $4.92B | $4.84B | $4.97B | $4.86B | $5.17B | $5.18B | $5.41B |
| EBITDA Avg | $2.38B | $2.52B | $2.48B | $2.54B | $2.49B | $2.65B | $2.65B | $2.77B |
| Low | $2.32B | $2.44B | $2.40B | $2.46B | $2.41B | $2.56B | $2.57B | $2.68B |
| High | $2.51B | $2.65B | $2.60B | $2.67B | $2.61B | $2.78B | $2.78B | $2.91B |
| EBIT Avg | $1.90B | $2.01B | $1.98B | $2.03B | $1.99B | $2.11B | $2.12B | $2.21B |
| Low | $1.85B | $1.95B | $1.92B | $1.97B | $1.92B | $2.05B | $2.05B | $2.14B |
| High | $2.00B | $2.11B | $2.08B | $2.13B | $2.09B | $2.22B | $2.22B | $2.32B |
| Net Income Avg | $1.23B | $1.32B | $1.21B | $1.35B | $1.35B | $1.43B | $1.33B | $1.52B |
| Low | $1.20B | $1.27B | $1.16B | $1.30B | $1.30B | $1.37B | $1.27B | $1.46B |
| High | $1.29B | $1.41B | $1.29B | $1.44B | $1.44B | $1.52B | $1.41B | $1.62B |
| EPS Avg | $2.01 | $2.16 | $1.98 | $2.21 | $2.21 | $2.33 | $2.17 | $2.48 |
| Low | $1.96 | $2.07 | $1.90 | $2.12 | $2.12 | $2.24 | $2.08 | $2.38 |
| High | $2.11 | $2.30 | $2.11 | $2.35 | $2.35 | $2.49 | $2.31 | $2.65 |
| Analysts (Rev / EPS) | 12 / 14 | 11 / 10 | 6 / 10 | 6 / 6 | 6 / 7 | 6 / 6 | 6 / 7 | 5 / 7 |